polyoxin L - Compound Summary (CID 100013)
structure given in first source
Table of Contents Drug and Chemical Information: (Total:1)
BioActivity Results:
Tested in BioAssays: All: 1 Inactive: 1 BioActivity Summary: This Compound with Similar Compounds
AID: 256 Source: DTP/NCI NCI In Vivo Anticancer Drug Screen. Data for tumor model L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice
|
Properties Computed from Structure:
Molecular Weight | 477.38012 [g/mol] | Molecular Formula | C16H23N5O12 | XLogP3-AA | -7.7 | H-Bond Donor | 9 | H-Bond Acceptor | 13 | Rotatable Bond Count | 10 | Tautomer Count | 12 | Exact Mass | 477.134321 | MonoIsotopic Mass | 477.134321 | Topological Polar Surface Area | 284 | Heavy Atom Count | 33 | Formal Charge | 0 | Complexity | 837 | Isotope Atom Count | 0 | Defined Atom StereoCenter Count | 0 | Undefined Atom StereoCenter Count | 8 | Defined Bond StereoCenter Count | 0 | Undefined Bond StereoCenter Count | 0 | Covalently-Bonded Unit Count | 1 |
Descriptors Computed from Structure:
IUPAC Name: 2-[(2-amino-5-carbamoyloxy-3,4-dihydroxypentanoyl)amino]-2-[5-(2, 4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid
Canonical SMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)C(C(=O)O)NC(=O)C(C(C(COC(=O)N)O)O)N)O)O
InChI: InChI=1S/C16H23N5O12/c17-6(8(24)4(22)3-32-15(18)30)12(27)20-7(14(28)29) 11-9(25)10(26)13(33-11)21-2-1-5(23)19-16(21)31/h1-2,4,6-11,13,22,24-26H, 3,17H2,(H2,18,30)(H,20,27)(H,28,29)(H,19,23,31)
InChIKey: XQOJMTZGJFOLKB-UHFFFAOYSA-N
Compound Information:
Substance Information:
Substances: 6 Links
Category: [for same structure substances]
|
|
|
|
| Compound ID | 100013 |
| Molecular Weight | 477.38012 [g/mol] |
| Molecular Formula | C16H23N5O12 |
| XLogP3-AA | -7.7 |
| H-Bond Donor | 9 |
| H-Bond Acceptor | 13 |
|
Links |
|